Filter posts

Parallel Importation: A Disincentive for Developing World Access to Medicines

Parallel importation serves as a challenge to improving access to medicines in the developing world.  …

Brazil Patent Policy: At a Crossroads

The Government of Brazil approaches the patent policy crossroads with two ministries wanting to move …

BIO IP Counsels Committee Conference: Spring 2013 Line-Up

San Diego, California is the next site for the BIO IP Counsels Committee Conference.  On …

Patently Biotech's Top 5 Articles of 2012

2012 has been an eventful year for biotech IP issues.  Below are the top 5 …

Whole Genome Sequencing and Myriad Supreme Court Case: Nothing to See Here

Bio IT World just published an article stating that the Myriad Supreme Court case will …

Inter Partes Review – a Useful Tool for Overcoming Freedom-to-Operate Obstacles

By Eric K. Steffe, Eldora L. Ellison, Ph.D., Todd Spalding, and Deborah A. Sterling, Ph.D. …

Traditional Knowledge and Genetic Resources: India Misses the Mark

India recently asked the global community for comments on its “Draft Guidelines for Processing of …

The ‘Access to Medicines’ Debate: Throwing Patients Without Cures Under the Proverbial Bus

The vast majority of the world’s patients remain completely forgotten in the ‘access to medicines’ …

SIPO Examiner Workshop: Biotech Patent Practices in the U.S., China and Japan

The biotechnology industry is an invention-intensive industry that relies heavily on the protection of intellectual …

Biotech Patenting Event: BIO’s 2012 Fall IPCC in Charleston, South Carolina

BIO’s 2012 Fall IPCC Conference event on November 12-14 gathers biotech in-house counsels to provide …